We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

33 hedge funds and large institutions have $88.7M invested in Global Cord Blood Corporation in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

14% more funds holding

Funds holding: 2933 (+4)

5% more capital invested

Capital invested by funds: $84.2M → $88.7M (+$4.48M)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
11
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q1 2017 in Review

33 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2017, worth a combined $88.7M — up 5.3% from $84.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CO positions and 2 closed out — a net gain of 4 holders — while 9 added to existing stakes and 11 trimmed.

The largest buyer was Capstone Investment Advisors, opening a new position worth an estimated $668K. The largest seller was Skandinaviska Enskilda Banken (SEB), cutting an estimated $1.48M.

  • 33 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2017, up from 29 in Q4 2016.
  • Funds reported $88.7M of Global Cord Blood Corporation stock for Q1 2017, up 5.3% quarter-over-quarter.
  • 6 funds opened new Global Cord Blood Corporation positions in Q1 2017 and 2 closed out, a net change of +4 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2017 was Capstone Investment Advisors, an estimated $668K added.
  • The largest Global Cord Blood Corporation seller in Q1 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $1.48M sold.

Based on aggregated 13F filings for Q1 2017.